Should I buy Cognex (CGNX) stock or is it too late?
⭐ The most reliable of them, either direction: Cantor Fitzgerald — 88% of its targets hit on this sector (8 calls tested). It aims for $84 (+33 %), call made on August 8, 2026, maturing on August 8, 2027 (20 d ago).
Firm-by-firm track record on Cognex
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Needham | 47 % | +8.4 % | 19 | $80 +27% |
| Goldman Sachs | 40 % | -30.6 % | 10 | $80 +27% |
| Raymond James | 64 % | +7.0 % | 11 | — |
| CLSA | 60 % | +6.4 % | 5 | — |
| Morgan Stanley | 64 % | -1.6 % | 11 | — |
✅ Reasons to believe
- 60% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
- Median price target $78, i.e. +24% from the current price ($63).
- The most reliable firm on CGNX, Stephens & Co. (100% hit rate, 3 scored calls), targets $75 (call made on May 7, 2026, maturing on May 7, 2027) (+19%) in its most recent call.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 10 ratings, 4 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- Negligible dividend (0.5% yield): your return depends mostly on price appreciation.
The analyst consensus on CGNX
Median target $78 (+24%) · 10 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Cognex now?
We won't decide for you. The facts: 60% of analysts rate it a buy, median target $78 (+24%), and Stephens & Co. (most reliable on CGNX, 100%) targets $75. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Cognex?
Not according to analysts: the median target ($78) is still +24% above the current price ($63) (most reliable on CGNX: Stephens & Co., 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Cognex still worth investing in?
It depends on the gap between the price ($63) and its estimated value: analysts target $78 on median (+24%), with 60% buys (most reliable on CGNX: Stephens & Co., 100%). Cross-check with their real reliability on CGNX and the cautions above. Information, not advice.
What's the main risk in buying CGNX?
The consensus is not unanimous: of 10 ratings, 4 are neutral.
→ Go deeper: the full Cognex profile (consensus, analyst reliability, price target, performance).